DT3C is a recombinant protein mainly used for in vitro evaluation of internalization efficiency of cancer cell towards monoclonal antibodies (mAb), thereby enabling the screening of more effective monoclonal antibodies. This protein consists of a diphtheria toxin (DT) protein without a receptor binding domain and Streptococcus protein G.
Compared to currently common techniques for evaluating antibody internalization efficiency, such as acid buffer elution, mAb-ZAP, pHrodo technology, the DT3C recombinant protein assay offers the advantages of simplicity in operation and precise quantification. It exhibits broad application prospects in the field of antibody internalization.
In vitro detection of ADC antibody internalization efficiency
Reference: M. Yamaguchi et al. Biochemical and Biophysical Research Communications 454 (2014) 600-603.
The DT3C recombinant protein from CUSABIO is expressed from Escherichia coli expression system. It's verified by SDS-PAGE and detected by SEC-HPLC, with a purity of over 90%.
After incubating different concentrations of DT3C protein with CCR8 antibody at 37°C for 30 minutes, the mixture was added to a culture plate and incubated for 48 hours. The range of EC50 values are 0.5795-1.400 μg/mL and 0.5608-1.318 μg/mL respectively.
CT26/Human CCR8 Stable Cell Line: 5000 cells/well
BMK-1/2: 10μg/mL
Experimental steps: